Perspectives on vitamin D therapy in chronic kidney disease.
Karalis
Maria
M
Abbott Laboratories, Abbott Park, IL, USA.
D004872:Ergocalciferols / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D006961:Hyperparathyroidism / Q000209:etiology / Q000517:prevention & control; D018167:Receptors, Calcitriol / Q000819:agonists; D051436:Renal Insufficiency, Chronic / Q000150:complications*; D014807:Vitamin D / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use*; D014808:Vitamin D Deficiency / Q000188:drug therapy* / Q000209:etiology
D004872:Ergocalciferols; D018167:Receptors, Calcitriol; D014807:Vitamin D; C084656:paricalcitol